Clinical Trial Update: Study to Evaluate the Safety and Efficacy of ASC40 in Subjects With Moderate to Severe Acne Vulgaris [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 clinical trial evaluating ASC40 for moderate to severe acne vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• ASC40

Snippet

Sponsor: Ascletis Pharmaceuticals Co., Ltd. | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED